{"transactions":[{"id":2647536,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":43804,"kind":"person","name":"Silvers Daniel B.","position":1,"cik":"0001468195","reported_name":"Silvers Daniel B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137681,"kind":"organization","name":"Matthews Lane Capital Partners LLC","position":2,"cik":"0001722952","reported_name":"Matthews Lane Capital Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137682,"kind":"organization","name":"MLCP GLL Funding LLC","position":3,"cik":"0001722935","reported_name":"MLCP GLL Funding LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2021-07-01T23:50:59.000Z","date":"2021-06-30","kind":"disposition_to_issuer","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"MLCP GLL Funding LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Reflects warrants surrendered to the Issuer in connection with the Issuer's business combination pursuant to a warrant surrender agreement, for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Reflects warrants surrendered to the Issuer in connection with the Issuer's business combination pursuant to a warrant surrender agreement, for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Matthews Lane Capital Partners LLC, a sponsor of the Issuer, is the manager of MLCP GLL Funding LLC, the record holder of the warrants. Mr. Silvers is the managing member of Matthews Lane Capital Partners LLC and disclaims beneficial ownership with respect to the securities except to the extent of his pecuniary interest therein."}],"balance_after":1754497,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-30","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-21-015899","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468195/000149315221015899/ownership.xml","form_type":"4"}},{"id":2647535,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":43804,"kind":"person","name":"Silvers Daniel B.","position":1,"cik":"0001468195","reported_name":"Silvers Daniel B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137681,"kind":"organization","name":"Matthews Lane Capital Partners LLC","position":2,"cik":"0001722952","reported_name":"Matthews Lane Capital Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137682,"kind":"organization","name":"MLCP GLL Funding LLC","position":3,"cik":"0001722935","reported_name":"MLCP GLL Funding LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2021-07-01T23:50:59.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":367107,"price":1,"value":367107.0,"ownership":{"direct":false,"nature":"MLCP GLL Funding LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Reflects warrants acquired at a price of $1.00 per warrant upon the conversion of promissory notes of the Issuer reflecting amounts loaned to the Issuer pursuant to the Issuer's expense advancement agreement, which were convertible into warrants at the holder's option. The warrants are on the same terms as the warrants described in note (1) above."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects warrants acquired at a price of $1.00 per warrant upon the conversion of promissory notes of the Issuer reflecting amounts loaned to the Issuer pursuant to the Issuer's expense advancement agreement, which were convertible into warrants at the holder's option. The warrants are on the same terms as the warrants described in note (1) above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Matthews Lane Capital Partners LLC, a sponsor of the Issuer, is the manager of MLCP GLL Funding LLC, the record holder of the warrants. Mr. Silvers is the managing member of Matthews Lane Capital Partners LLC and disclaims beneficial ownership with respect to the securities except to the extent of his pecuniary interest therein."}],"balance_after":2004497,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-30","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":367107},"source":{"system":"sec-edgar","filing":"0001493152-21-015899","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468195/000149315221015899/ownership.xml","form_type":"4"}},{"id":2647534,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":43804,"kind":"person","name":"Silvers Daniel B.","position":1,"cik":"0001468195","reported_name":"Silvers Daniel B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137681,"kind":"organization","name":"Matthews Lane Capital Partners LLC","position":2,"cik":"0001722952","reported_name":"Matthews Lane Capital Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137682,"kind":"organization","name":"MLCP GLL Funding LLC","position":3,"cik":"0001722935","reported_name":"MLCP GLL Funding LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2021-07-01T23:50:59.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":1637390,"price":1,"value":1637390.0,"ownership":{"direct":false,"nature":"MLCP GLL Funding LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects warrants of Ensysce Biosciences, Inc., formerly known as Leisure Acquisition Corp. (the \"Issuer\"), which were acquired from the Issuer at a price of $1.00 per warrant in a private placement that closed simultaneously with the closing of the Issuer's initial public offering which were later exchanged for warrants having the same terms, except that they are non-transferable other than to permitted transferees. Pursuant to the terms of the issuance, such warrants were not eligible to become exercisable unless the Issuer consummated its initial business combination which occurred on June 30, 2021. Mr. Silvers served as the Issuer's Chief Executive Officer and Director until the closing of the business combination."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects warrants of Ensysce Biosciences, Inc., formerly known as Leisure Acquisition Corp. (the \"Issuer\"), which were acquired from the Issuer at a price of $1.00 per warrant in a private placement that closed simultaneously with the closing of the Issuer's initial public offering which were later exchanged for warrants having the same terms, except that they are non-transferable other than to permitted transferees. Pursuant to the terms of the issuance, such warrants were not eligible to become exercisable unless the Issuer consummated its initial business combination which occurred on June 30, 2021. Mr. Silvers served as the Issuer's Chief Executive Officer and Director until the closing of the business combination."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Matthews Lane Capital Partners LLC, a sponsor of the Issuer, is the manager of MLCP GLL Funding LLC, the record holder of the warrants. Mr. Silvers is the managing member of Matthews Lane Capital Partners LLC and disclaims beneficial ownership with respect to the securities except to the extent of his pecuniary interest therein."}],"balance_after":1637390,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-30","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":1637390},"source":{"system":"sec-edgar","filing":"0001493152-21-015899","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468195/000149315221015899/ownership.xml","form_type":"4"}},{"id":4097814,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":43804,"kind":"person","name":"Silvers Daniel B.","position":1,"cik":"0001468195","reported_name":"Silvers Daniel B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}},{"id":137681,"kind":"organization","name":"Matthews Lane Capital Partners LLC","position":2,"cik":"0001722952","reported_name":"Matthews Lane Capital Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsors of the Co."}},{"id":137682,"kind":"organization","name":"MLCP GLL Funding LLC","position":3,"cik":"0001722935","reported_name":"MLCP GLL Funding LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsor Affiliate of the Co."}}],"security":"Common Stock","published_at":"2018-01-17T22:18:54.000Z","date":"2018-01-15","kind":"other","acquired":false,"shares":171832,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As contemplated by the securities subscription agreement between each reporting person and the Company, 171,832 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the \"Sponsor\"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As contemplated by the securities subscription agreement between each reporting person and the Company, 171,832 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the \"Sponsor\"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 887,127 shares of common stock held by the Sponsor Affiliate. Represents 241,243 shares of common stock held by the Sponsor. The shares held by the Sponsor Affiliate and the Sponsor are beneficially owned by\nDaniel B. Silvers, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate and the Sponsor. Mr. Silvers owns all of the membership interests in the Sponsor Affiliate and the Sponsor. Mr. Silvers disclaims beneficial ownership over any securities owned by the Sponsor and the Sponsor Affiliate in which he does not have any pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents 887,127 shares of common stock held by the Sponsor Affiliate. Represents 241,243 shares of common stock held by the Sponsor. The shares held by the Sponsor Affiliate and the Sponsor are beneficially owned by\nDaniel B. Silvers, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate and the Sponsor. Mr. Silvers owns all of the membership interests in the Sponsor Affiliate and the Sponsor. Mr. Silvers disclaims beneficial ownership over any securities owned by the Sponsor and the Sponsor Affiliate in which he does not have any pecuniary interest."}],"balance_after":1128370,"source":{"system":"sec-edgar","filing":"0001615774-18-000382","document":"s108737_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468195/000161577418000382/s108737_form4.xml","form_type":"4"}},{"id":4141931,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":43804,"kind":"person","name":"Silvers Daniel B.","position":1,"cik":"0001468195","reported_name":"Silvers Daniel B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}},{"id":137681,"kind":"organization","name":"Matthews Lane Capital Partners LLC","position":2,"cik":"0001722952","reported_name":"Matthews Lane Capital Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsor of the Company"}},{"id":137682,"kind":"organization","name":"MLCP GLL Funding LLC","position":3,"cik":"0001722935","reported_name":"MLCP GLL Funding LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Sponsor Affiliate of the Co."}}],"security":"Common Stock","published_at":"2017-12-05T23:57:12.000Z","date":"2017-12-05","kind":"other","acquired":false,"shares":359869,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As contemplated by the securities subscription agreement between each reporting person and the Company, 359,869 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the \"Sponsor\"), were forfeited upon consummation of the Company's initial public offering for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As contemplated by the securities subscription agreement between each reporting person and the Company, 359,869 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the \"Sponsor Affiliate\") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the \"Sponsor\"), were forfeited upon consummation of the Company's initial public offering for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 171,833 shares held by the Sponsor Affiliate and the Sponsor that are subject to forfeiture to the extent that the underwriters' overallotment in the Company's initial public offering is not fully exercised."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 1,022,222 shares of common stock held by the Sponsor Affiliate. Represents 277,980 shares of common stock held by the Sponsor. The shares held by the Sponsor Affiliate and the Sponsor are beneficially owned by Daniel B. Silvers, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate and the Sponsor. Mr. Silvers owns all of the membership interests in the Sponsor Affiliate and the Sponsor. Mr. Silvers disclaims beneficial ownership over any securities owned by the Sponsor and the Sponsor Affiliate in which he does not have any pecuniary interest."}],"balance_after":1300202,"source":{"system":"sec-edgar","filing":"0001144204-17-062472","document":"tv480824_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468195/000114420417062472/tv480824_4.xml","form_type":"4"}}]}